Vowst
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Vowst is indicated for preventingClostridioides difficile infection (CDI) recurrence in patients ≥ 18 years of age following antibacterial treatment for recurrent CDI.
- Vowst should NOT be given for the treatment of active CDI.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved